General Information of the Compound
Compound ID
CP0537451
Compound Name
Pf-05241328
    Show/Hide
Synonyms
PF-05241328
    Show/Hide
Structure
Formula
C19H21ClN4O4S
Molecular Weight
436.921
Canonical SMILES
CC(C)COc1ncc(cc1Cl)-n1nc(C)c2cc(ccc12)C(=O)NS(C)(=O)=O
    Show/Hide
InChI
InChI=1S/C19H21ClN4O4S/c1-11(2)10-28-19-16(20)8-14(9-21-19)24-17-6-5-13(7-15(17)12(3)22-24)18(25)23-29(4,26)27/h5-9,11H,10H2,1-4H3,(H,23,25)
    Show/Hide
InChIKey
RVTSXVZXEGFIPW-UHFFFAOYSA-N
CAS
1387633-03-5
Physicochemical Property
logP
3.10652
Rotatable Bonds
6
Heavy Atom Count
29
Polar Areas
103.18
Hydrogen Bond Donor Count
1
Hydrogen Bond Acceptor Count
7
Complexity
29

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 68109743
ChEMBL ID
CHEMBL4279521
DrugBank ID
DB15124
Clinical Information about the Compound
Drug 1 ( PF-05241328 )
Drug Name PF-05241328
Company Pfizer Inc
Indication
Pain
Phase 1
Target(s)
Voltage-gated sodium channel alpha Nav1.7 (SCN9A)
Inhibitor